Fri, Aug 26, 2016
A A A
Welcome Guest
Free Trial RSS
Get FREE trial access to our award winning publications
Industry Updates

Barclay Hedge Fund Index slips 0.29% in January; Healthcare & Biotechnology opens 2014 with 5.97% gain

Wednesday, February 19, 2014
Opalesque Industry Update - Hedge funds lost 0.29% in January, according to the Barclay Hedge Fund Index compiled by BarclayHedge. The Index gained 11.11% in 2013.

“After a rousing end to 2013, January bore witness to a complete reversal of key trends as investor sentiment turned defensive,” says Sol Waksman, founder and president of BarclayHedge.

“Global equity markets sold off as emerging markets came under renewed pressure from slowing in China, political unrest in Thailand and Turkey, and currency devaluation in Argentina." Overall performance by hedge fund sector was mixed in January. Twelve of Barclay’s 18 hedge fund indices had gains, while six indices had losses.

The Barclay Healthcare & Biotechnology Index jumped 5.97% in January, its largest one-month return since posting a gain of 6.27% in May of 2009.

“The Healthcare sector was a beneficiary of the move by investors out of cyclical stocks and into defensive stocks,” says Waksman.

The Barclay Equity Short Bias was up 1.95% in January, Distressed Securities gained 1.55%, European Equities were up 1.20%, Convertible Arbitrage gained 1.10%, and Fixed Income Arbitrage rose 0.94%.

In contrast, the Emerging Markets Index lost 2.47%, Pacific Rim Equities were down 0.96%, Equity Long Bias gave up 0.86%, anf Global Macro lost 0.55%.

The Barclay Fund of Funds Index was down 0.36% in January.

BarclayHedge

Press Release

BM

What do you think?

   Use "anonymous" as my name    |   Alert me via email on new comments   |   
Today's Exclusives Today's Other Voices More Exclusives
Previous Opalesque Exclusives                                  
More Other Voices
Previous Other Voices                                               
Access Alternative Market Briefing

 



  • Top Forwarded
  • Top Tracked
  • Top Searched
  1. Opalesque Exclusive: Algorithms platform aims to target typical challenges found in quantitative hedge funds[more]

    Benedicte Gravrand, Opalesque Geneva: Last month, Quantopian received investments from Point72 Ventures, the new venture capital arm of Steven Cohen’s Point72 Asset Management.

  2. LatAm hedge funds surge in 1H to +24.4%, emerging markets assets rise[more]

    Komfie Manalo, Opalesque Asia: Hedge funds investing in Latin America posted strong gains through mid-2016, reversing declines in four of the past five years, including the last three years, to lead all areas of hedge fund performance through the first half of 2016, according to the latest HFR Em

  3. Asia - LGT Capital Partners: Alternatives set for continued rise in Asia[more]

    From Asianinvestor.net: More flows are likely into insurance-linked strategies, private equity and trend-following strategies/CTAs, given the benefits of such investments, argues LGT Capital Partners. Despite the numerous quantitative easing programs and bailouts of recent years, the quest for

  4. Opalesque Roundtable: Low and high fee investments often better than mid fee hedge funds[more]

    Komfie Manalo, Opalesque Asia: Hedge funds that charge the low and high fees stuff often provide better returns than "those sort of mid-fee investments", said Keith Haydon, chief investment officer of Man FRM. (Alternative) investment managers who charge high fees would often provide the most int

  5. Hedge fund investors pull $5.7 billion in July[more]

    From Bloomberg.com: Hedge funds suffered a third consecutive month of outflows in July as investors withdrew $5.7 billion, according to industry tracker Eurekahedge. Redemptions totaled $20.7 billion in the three months through July, with money managers betting on equities suffering $18.4 bill